China Universal Asset Management Company’s Coherus Oncology CHRS Stock Holding History

China Universal Asset Management Company’s Portfolio CHRS Stock Details CHRS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$28K	Buy
2024 Q4	–	Sell
2024 Q3	$23K	Buy
2024 Q2	$23.3K	Sell
2024 Q1	$51.2K	Buy
2023 Q4	$42.9K	Buy
2023 Q3	$9.07K	Buy
2023 Q2	$5.26K	Buy
2023 Q1	$7.21K	Buy
2022 Q4	$6.26K	Buy
2022 Q3	$7K	Buy